The PE Ratio as of December 2025 (TTM) for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) is 21.85

According to Jagsonpal Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is 21.85. This represents a change of -33.98% compared to the average of 33.09 of the last 4 quarters.

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) Historical PE Ratio (quarterly & annually)

How has JAGSNPHARM.NS PE Ratio performed in the past?

The mean historical PE Ratio of Jagsonpal Pharmaceuticals Limited over the last ten years is 18.82. The current 21.85 PE Ratio has changed 11.51% with respect to the historical average. Over the past ten years (40 quarters), JAGSNPHARM.NS's PE Ratio was at its highest in in the March 2022 quarter at 8.21K. The PE Ratio was at its lowest in in the March 2018 quarter at -14.68.

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Jagsonpal Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) Average PE Ratio

How has JAGSNPHARM.NS PE Ratio performed in the past?

The current PE Ratio of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) PE Ratio vs. Peers

How is JAGSNPHARM.NS’s PE Ratio compared to its peers?

Jagsonpal Pharmaceuticals Limited’s PE Ratio is less than Bajaj HealthCare Limited (28.84), less than Bajaj HealthCare Limited (28.84), greater than Syncom Formulations (India) Limited (21.14), greater than Syncom Formulations (India) Limited (21.14), greater than Bliss GVS Pharma Limited (16.66), greater than Bliss GVS Pharma Limited (16.66), less than Hester Biosciences Limited (31.02), less than Hester Biosciences Limited (31.02), greater than Megasoft Limited (9.35), greater than Sigachi Industries Limited (-23.73),

Build a custom stock screener for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jagsonpal Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jagsonpal Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.